Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | 12-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 7,813 | 658 | N/A | N/A | N/A |
| Receivables | 8,000 | N/A | N/A | N/A | N/A |
| TOTAL | $16,062 | $658 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 155 | 21 | N/A | N/A | N/A |
| TOTAL | $155 | $21 | $N/A | $N/A | $N/A |
| Total Assets | $16,217 | $679 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 428 | 267 | 0 | 0 | 0 |
| Accrued Expenses | 751 | 360 | N/A | N/A | N/A |
| Other current liabilities | 52 | N/A | N/A | N/A | N/A |
| TOTAL | $3,181 | $4,627 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Deferred Revenues | 1,950 | N/A | N/A | N/A | N/A |
| TOTAL | $6,050 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $9,231 | $4,627 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 1 | 1 | N/A | N/A | N/A |
| Retained earnings | -14,739 | -7,955 | N/A | N/A | N/A |
| Other shareholders' equity | 21,624 | 3,996 | 0 | 0 | 0 |
| TOTAL | $6,986 | $-3,948 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $16,217 | $679 | $0 | $0 | $0 |